AbbVie Jumps After Hiking Its Outlook On The Back Of Strong Immunology SalesInvestors Business Daily • 04/25/25
Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) Seeking Recovery for Investors - Contact Levi & KorsinskyAccesswire • 04/25/25
5 Rock-Solid Passive Income Dividend Aristocrats That Are Reasonably Safe From Tariffs24/7 Wall Street • 04/25/25
Lost Money on Cerevel Therapeutics Holdings, Inc.(ABBV)? Join Class Action Suit Seeking Recovery – Contact Levi & KorsinskyGlobeNewsWire • 04/24/25
Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - ABBVAccesswire • 04/24/25
AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar LinesPRNewsWire • 04/24/25
The Gross Law Firm Reminds Cerevel Therapeutics Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - ABBVPRNewsWire • 04/24/25
Buy Stock in These Healthcare Leaders as Q1 Earnings Approach? ABBV, HCAZacks Investment Research • 04/24/25
Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights – ABBVGlobeNewsWire • 04/23/25
Shareholders that lost money on Cerevel Therapeutics Holdings, Inc. (ABBV) should contact Levi & Korsinsky about pending Class Action - ABBVAccesswire • 04/23/25
Seeking Clues to AbbVie (ABBV) Q1 Earnings? A Peek Into Wall Street Projections for Key MetricsZacks Investment Research • 04/22/25
Will These 5 Large Drug Maker Stocks Surpass Q1 Earnings Forecast?Zacks Investment Research • 04/22/25
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cerevel Therapeutics Holdings, Inc.(ABBV) ShareholdersPRNewsWire • 04/22/25
Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) Seeking Recovery for Investors – Contact Levi & KorsinskyGlobeNewsWire • 04/21/25
The Gross Law Firm Notifies Cerevel Therapeutics Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ABBVPRNewsWire • 04/21/25